Traditional Chinese medicine composition for treating central retinitis and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine composition for treating central retinitis, which is prepared from the following raw materials in parts by weight: 10-40 parts of phaseolus calcaratus, 1-16 parts of rhizoma alismatis, 5-25 parts of poria, 1-16 parts of radix stephaniae tetrandrae, 2-22 parts of radix astragali, 5-25 parts of radix salviae miltiorrhizae, 1-20 parts of Chinese angelica, 1-20 parts of rhizoma atractylodis macrocephalae, 5-25 parts of earthworm, 1-20 parts of herba epimedii, 1-20 parts of cassia twig, 8-28 parts of caulis spatholobi and 1-13 parts of liquorice root. The traditional Chinese medicine composition disclosed by the invention has moderate property and good curative effect, and is used for treating central retinitis without laser photocoagulation.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating central retinitis, and to a preparation method of the traditional Chinese medicine composition. Background technique [0002] Central retinitis, also known as central serous chorioretinopathy, is a fundus lesion caused by pigment epithelial barrier dysfunction and serous detachment of retinal neuroepithelium in the macula. Acute medium, chronic medium and bullous retinal detachment. [0003] This disease mostly occurs in young and middle-aged people. When the onset occurs, one eye is affected, with metamorphopsia, diminution, and discoloration. There is a round gray or brownish-yellow shadow in the middle of the eyes, and the fovea reflection of the fundus is diffuse. [0004] Based on the understanding that infarction is a self-limiting disease, many ophthalmologists pursue a conservative approach in the treatment of infar...

AI Technical Summary

Problems solved by technology

However, clinical practice has shown that laser photocoagulation can seal RPE leakage points, accelerate the absorption of serous RPE detachment, shorten the course of the disease, and benefit vision recovery; however, long-term observations have found that laser photocoagulation has not shown that it can improve the long-term efficacy of patients or reduce the recurrence rate